Food and Drug Administration, et al., Petitioners v. Alliance for Hippocratic Medicine, et al.
Case Number:
23-235
Court:
Nature of Suit:
Firms
- Akin Gump
- American Center for Law & Justice Inc.
- Arnold & Porter
- Consovoy McCarthy
- Cooper & Kirk
- Covington & Burling
- Crowell & Moring
- Debevoise & Plimpton
- Envisage Law
- Faegre Drinker
- Fried Frank
- Goodwin Procter
- Hacker Stephens
- Hogan Lovells
- Holwell Shuster
- Independence Law Center
- Jenner & Block
- Kaplan Hecker
- King & Spalding
- Kroger Gardis
- Patterson Belknap
- Ropes & Gray
- Simpson Thacher & Bartlett LLP
- Skadden Arps
- WilmerHale
- Zuckerman Spaeder
Companies
- American Bar Association
- American Civil Liberties Union
- American Psychological Association
- Americans United for Life
- Asian Americans Advancing Justice
- Association of American Medical Colleges
- Charlotte Lozier Institute
- Family Policy Alliance
- Judicial Watch Inc.
- NAACP Legal Defense & Educational Fund Inc.
- National Association for the Advancement of Colored People
- Pharmaceutical Research & Manufacturers of America
- Public Citizen Inc.
Government Agencies
Sectors & Industries:
-
November 08, 2023
Justices Told To Ignore Group's Take On Abortion Pill OK
The federal government and a distributor of the abortion pill mifepristone urged the U.S. Supreme Court to reject an organization's argument over its challenge to the U.S. Food and Drug Administration's approval of the medication, saying that millions of women have used it to safely terminate pregnancies.
-
October 17, 2023
Abortion Foes Ask For Full Review Or Nothing In Drug Appeal
Anti-abortion activists are telling the U.S. Supreme Court that if the justices review parts of a Fifth Circuit ruling reinstating the approval of an abortion medication, they should consider the entire case.
-
October 13, 2023
Supreme Court Deluged With Calls To Hear Abortion Pill Battle
Politicians, doctors, legal professors and pharmaceutical companies have turned out en masse to urge the U.S. Supreme Court to review a Fifth Circuit panel's decision that would significantly curb access to the abortion medication mifepristone nationwide, attacking the ruling as deeply flawed and warning of its potentially seismic effects beyond abortion access.
-
September 08, 2023
Justices Urged To Hear Fight Over Abortion Pill Restrictions
The U.S. Department of Justice and a distributor of the abortion medication mifepristone urged the U.S. Supreme Court on Friday to review a Fifth Circuit decision that threatens to curb access to the drug, marking the latest chapter in the national battle over abortion access following Roe v. Wade's reversal.
- ← Previous
- 1
- 2
- 3
- 4
- Next →